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TITLE: Are women empowered to make decisions about the use of 
antidepressants in pregnancy?  
 
Abstract:  
Background: Untreated depression is related to adverse maternal mortality and 
morbidity. The most frequent treatment option for women is antidepressant medication. 
Women find decision-making about antidepressant usage in pregnancy difficult and 
confusing. There is a dearth of information to explain if women are empowered to make 
decisions around the use of antidepressants in pregnancy.  
Method: A literature review was conducted using Cinahl Complete, Intermid, Proquest 
and Discover More.  
Results: Information provision was inadequate and women experienced decisional 
conflict. Women wanted to be involved in a collaborative decision-making process. 
Conclusion: Women want to be provided with clear and accurate information and 
follow a collaborative decision-making process when making decisions about 
antidepressants in pregnancy. More research is needed to explore demographic gaps 
within population samples. Women’s experiences of decision-making about 
antidepressant usage need to be explored in depth. Undergraduate and postgraduate 
2 
 
health education should include conversation skills training, associated with 




  There is a need to provide clear information about the risks and benefits of 
antidepressant usage during pregnancy.  
 Women want their healthcare professionals to facilitate collaborative discussion with 
them about treatment options.  
 Feeling informed has a clear association with feeling satisfied when women make 
decisions about anti-depressant usage.  
 More research covering a wider demographic and with UK participants is necessary 
in order to better understand this topic.  
 

























Depression and anxiety are two of the most common health problems in 
pregnancy in the UK, with 12% of women experiencing depression and 13% 
experiencing anxiety (Heron et al, 2004; Gavin et al, 2005; Vesga-Lopez et al, 2008). 
The most common treatment is antidepressant medication (McManus et al, 2016). In 
2013, antidepressants were the most researched drugs during pregnancy, with over 
30,000 potential outcomes examining the risk of adverse effects on the fetus 
(Einarson, 2013). Furthermore, antidepressant usage in pregnancy has been linked 
with spontaneous abortion, maternal morbidity and adverse neonatal outcome such 
as; low birth weight, pre-term delivery, congenital malformations, neonatal withdrawal 
syndrome and persistent pulmonary hypertension of the newborn (Bonari et al, 2004; 
Chan et al, 2014; UK Teratology Information Service (UKTIS), 2016). However, risks 
are difficult to quantify due to conflicting findings from teratological research (UKTIS, 
2016) and the observational methods used, since pregnant women are not included in 
randomised controlled trials for antidepressant drugs (Einarson et al, 2015). Ambiguity 
around risk factors makes decision-making about antidepressant usage during 
pregnancy a complex process (Bonari et al, 2005; Patel et al, 2011; Stepanuk et al, 
2013; Walton et al, 2014). Therefore, this literature review seeks to explore whether 
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women feel they are empowered to make complex decisions about antidepressants in 
pregnancy.  
 
Method and results  
This literature review focussed on papers using Boolean logic to incorporate 
the use of the word “AND” within the search strategy. For Example, “Pregnancy AND 
depression AND decision**” was used for the majority of the search. To enhance the 
search, reference lists from identified articles where reviewed for relevance. The 
search used Cinahl Complete, Intermid, ProQuest and Discover More data bases. The 
process to select relevant articles included screening by title and abstract (anonymised 
author initial). To add rigor, an independent review was undertaken (anonymised 
author). Selection revolved around the exclusion criteria and relevance to the topic.  
 
The focus of this paper related to women’s decision-making regarding the use 
of antidepressants. Therefore, papers were excluded if the main focus was on 
decision-making by clinicians, postpartum depression, the teratogenic effects of 
antidepressants, or there was no analysis of how women are empowered to make a 
decision (See Figure 1 for detail).  Countries similar to the UK in demographics were 
included. An expanded timeline was used to broaden the search due to the dearth of 
literature available (2000-2017). The selected articles were analysed using an 
appraisal tool adapted from CASP (2016) and Crombie’s (1996) checklists. 
 
(PLACE FIGURE 1. HERE.)  
 
Key findings from the literature review are outlined in Table 1, which reflect a 
significant weighting towards quantitative research, as three studies were quantitative 
(Stepanuk et al 2013; Patel and Wisner 2011; Bonari et al 2005) and one included a 
mixed methodology (Walton et al 2014). Available studies were set in the USA or 
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Canada. There was a lack of evidence around information provision and decision-
making in the antenatal period in a UK setting. The findings suggested a need for clear 
risk-benefit information for antidepressant usage. There was a strong indication that 
women wanted collaborative discussion about their antidepressant treatment options. 
Two key themes emerged from this literature review related to information provision 
and collaborative decision-making, which will be discussed further.  
 
(PLACE TABLE 1. HERE)  
 
 
Information Provision  
Information provision was cited as an important aspect of the decision-making 
process in all four studies reviewed. A mixed method, cross sectional study (n=50), by 
Walton et al (2014) looked at decisional conflict among pregnant women who were 
considering antidepressant usage. The quantitative aspect of the study focused on the 
Decisional Conflict Scale (DCS), a validated tool for studying complex decisions 
(O’Connor, 1995; Stacey et al, 2012), which provides a score indicating the level of 
decisional conflict experienced by the user. A DCS score of >37.5 indicated a high 
level of decisional conflict, a score of 25 to 37.5 indicated moderate decisional conflict 
and a score of <25 indicated low decisional conflict. It was found that women who were 
antidepressant users (n=21) had a much lower state of decisional conflict (DCS 
mean=17.5) in the ‘Informed’ subscale than women who were non-users (n=19, DCS 
mean=42.1). This indicated that women who were antidepressant users felt more 
informed than women who were non-users. The difference in scores was statistically 
significant (p=0.001), the low p value indicates there was little chance for error and is 
a robust finding (Crombie, 1996).  
Semi-structured interviews with women (n=10) reported a lack of high quality 
information (n=5) about risk in relation to the health of their baby (Walton et al, 2014). 
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All of the women interviewed went on to express the competing requirement to weigh 
their own health against the health of their baby as a barrier to decision-making.  This 
is in contrast to the previous quantitative finding from this same study that women felt 
less decisional conflict when they were informed. The number of participants involved 
(10) could be seen as limited, although Guest et al (2006) suggested that overarching 
themes can emerge from as few as six interviews. The limited number does impact on 
the generalisability of the findings, which is acknowledged by the authors. 
 
Information provision was also tested by Bonari et al (2005) in their structured 
telephone survey (n=100) of women calling the Motherrisk Medication Help Line. They 
found a positive correlation (Pearson’s r=0.391, p=<0.01) between information 
received and continuation with antidepressant usage.  However, there is no rationale 
given for the chosen sample size (n=100), therefore the correlation should be 
considered as weak because it may be underpowered (Bowling and Ebrahaim, 2005). 
 
In a further study, information provision by health care professionals was found 
to impact on the level of emancipation in the decision-making process, which was in 
turn linked to satisfaction about the decision made (Stepanuk et al, 2013). In addition, 
satisfaction with decision made was not significantly different between women who 
chose to take or not take antidepressant medication. Stepanuk et al (2013) also 
explored empowerment in decision-making using a cross-sectional, descriptive web 
based survey based on Wittman-Price’s (2004) theory of emancipated decision-
making (n=143). A statistically significant relationship between personal knowledge 
and satisfaction with decision (p=<0.001) was found. Personal knowledge was defined 
as the information women needed to weigh up the risks and benefits of taking 
antidepressant medication during pregnancy (Stepanuk et al, 2013). This finding can 
be treated as robust since the power calculation to define the sample size was set at 
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0.8, which is accepted as a good level in order to be able to detect statistically 
significant relationships (Sedgwick, 2011). 
 
Collaborative Decision-making 
It was apparent that women wanted to be actively involved in collaborative 
decision-making about anti-depressant usage (Patel and Wisner, 2011; Stepanuk et 
al, 2013 and Walton et al, 2014). Collaborative decision-making was tested in Patel 
and Wisner’s (2013) study, in which pregnant women (n=100) completed a structured 
online survey using three validated tools (1) The Decisional Conflict Scale (DCS), (2) 
The Control Preferences Scale (CPS) and (3) the Problem Solving Decision Making 
Scale (PSDMS) (O’Connor, 1995; Deber et al, 1996; Degner et al, 1997).  This survey 
split the decision-making process into two parts; Problem Solving (PS) and Decision-
Making (DM).  With regard to problem solving, the study found that 72% of women 
wanted to defer; 24% wanted to share, and only 4% wanted to keep sole responsibility 
for solving the problem. In comparison, in relation to decision-making, only 4% wanted 
to defer; 41% wanted to share and 55% wanted sole responsibility for the decision-
making process.  A potential interpretation of the findings suggest that women see the 
clinician as playing a crucial role in helping to understand how to weigh risk and benefit 
associated with treatment options and would like to take a passive role in this process. 
However, women would like the stance taken by the clinician to be the basis of a 
conversation related to helping women decide to take them or not. Regardless of the 
interpretation, the findings demonstrated a clear desire from women surveyed to play 
an active role in decision-making around usage of antidepressant medication.  
 
Strengths and Limitations 
There was an imbalance of available evidence to critique, since 3 studies were 
quantitative and 1 study used mixed methods. The balance within the mixed method 
study reflected a weighting towards 40 quantitative responses and only 10 qualitative 
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responses. Therefore, the perspective within this literature review reflects that 
imbalance of evidence, commenting on quantitative findings mostly and adding context 
and depth from the small amount of qualitative information available. All studies 
demonstrated a structured approach in their analysis and highlighted information about 
a topic that is little known about, specifically, how women make decisions about the 
use of antidepressants in pregnancy.  To our knowledge there are no comparable 
studies in the UK specifically related to how women decide to use antidepressants in 
pregnancy, with all four of the studies reviewed being set in the USA or Canada. It was 
apparent that bias was identified in all four of the studies as demographics suggested 
that the majority of participating women were described as white, married or living with 
a partner, or educated to a high school diploma level or higher. A comparison of the 
demographic details can be seen in Table 2. 
 
(PLACE TABLE 2. HERE.) 
 
Discussion 
This literature review has provided current and robust information reflecting that 
women are not empowered to make decisions about the use of antidepressants in 
pregnancy. Walton et al.’s findings (2014) show that women wanted clearer 
information from a source they trust, and identified that there is a proven relationship 
between feeling informed and having less conflict when deciding to take 
antidepressants. Walton et al’s (2014) finding that there was a significant difference in 
decisional conflict with between antidepressant users and non-users differs from 
Stepanuk at al.’s (2013) research, which found no statistically significant difference.   
Unfortunately, Stepanuk et al (2013) do not provide any qualitative data, so it is not 
possible to look in any depth at the reason behind this differing result.  Therefore, there 
is a need for researchers to explore in depth how women decide to take anti-




In addition, Walton et al.’s (2014) qualitative research suggests that many 
women perceived receiving information from a specialist mental health clinic to be 
more helpful to their decision-making process.  Unfortunately, Walton et al (2014) do 
not provide the number of women that reported this finding and therefore the finding 
should be treated with a degree of caution.  However, in the UK there are gaps in 
service provision related to support from mental health practitioners which has been 
associated with lack of funding, shortage of appropriately qualified staff and poor 
resources (Hogg 2013). 
Corroboration that women wanted information provided by specially trained 
mental health professionals is evidenced by the Guideline Development Group in their 
systematic review of qualitative research of UK women’s experience of antenatal and 
postnatal care around mental health (The British Psychological Society and The Royal 
College of Psychiatrists, 2015). The report suggested that there was a lack of 
information provided, the consequences of which were that many women stopped 
taking their medication on finding they were pregnant. This evidence formed the basis 
of the NICE (2014) recommendation that women should be provided with information 
on the risks and benefits of medication, the consequences of no treatment, and what 
might happen if medication is stopped. Evidence within that guideline relating 
specifically to information provision was UK based, but focussed on postnatal mental 
health only and was therefore excluded from this review. This finding highlights the 
lack of current research situated in the antenatal period around how women are 
empowered to make decisions about whether to use antidepressants or not. Therefore, 
it is easy to understand why women find decision-making difficult in the antenatal 
period (Walton et al 2014).  
 
Both Bonari et al (2005) and Walton et al (2014) found a relationship between 
information provided and continuation with antidepressant usage. Despite the 
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weakness of correlation and small sample sizes involved in the studies, it is important 
to acknowledge the link between information received and the decision to take 
antidepressant medication. This is particularly important in light of the known risks of 
untreated depression, such as reduced ability to form attachment to infants (Hayes et 
al, 2013), increased rates of premature delivery, increased frequency of NICU 
admission (Engelstad et al, 2014) and suicide, one of the largest contributors to 
maternal death (MBRACE-UK, 2016). 
 
Providing clear information about antidepressant usage in pregnancy is difficult 
for health care professionals to facilitate effectively due to the complexity of evidence 
surrounding the use of antidepressants in pregnancy (Einarson et al, 2015). Therefore, 
it is necessary for health care professionals to consider deeply how information is 
communicated. The need for a considered approach is echoed by Stepanuk et al 
(2013), who found that women were more satisfied with their decision when they felt 
more informed. Therefore, providing information in an accessible way that empowers 
women during the decision-making process makes a difference to the decision they 
make and to the satisfaction that they feel; even if the woman opts for no medication. 
 
The link that Patel and Wisner (2011) found between complex information and 
a desire to defer the problem solving aspect of the decision making process must also 
be acknowledged.  Only 4% of women wanted sole responsibility for this aspect, which 
included weighing risk and considering treatment options.  This indicates that women 
did not feel empowered at this stage of the process but did not want to relinquish the 
decision making since 96% of women (41% wanted shared and 55% wanted sole 
responsibility) in actually making the decision whether or not to use antidepressants.  
Active decision-making reflects a level of empowerment that can influence positive 
treatment outcomes, ranging from impact on the satisfaction with the decision made 
(Bruera et al, 2002 and Kunneman et al, 2014) to findings of a more positive outcome 
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in health up to 3 years after treatment (Hack et al, 2006). Patel and Wisner (2011) 
recommended that it is important to explore the woman’s expectations of the decision-
making process to improve communication and satisfaction with the process. 
 
A key finding within the studies reviewed focussed on the limited demographics 
(see Table 2). Patel and Wisner’s study (2011) found that younger women surveyed 
had a higher score in the ‘Informed’ subscale of the Decisional Conflict Scale (p=0.02), 
showing that younger women experience more conflict when they make decisions 
about antidepressant usage due to feeling uninformed. This highlights the need for 
further research encompassing a much wider demographic. Younger women were 
also identified by De Jonge (2001) as a group who needed specific and relevant 
information about mental health. This finding poses an important consideration around 
those who identify themselves as part of minority groups related to ethnicity, sexuality, 
learning disability or those who are less educated. 
 
It is important to take into account that all women participating in the evidence 
presented in this review had actively sought further advice or information about their 
depression diagnosis (Bonari et al, 2005, Patel and Wisner, 2011, Stepanuk et al, 
2013, Walton et al, 2014). It could be suggested that the nature of this self-help, 
coupled with the narrow demographic, might make the participants more motivated to 
gather information and share or take control of their situation. The general high level 
of education could also be said to contribute to a stronger need for detailed information. 
Further research with a wider demographic is needed to better understand this 
potential source of bias before a firm conclusion could be made. 
 
Conclusion / Recommendations 
It was clear from this analysis that women in the USA and Canada are not 
empowered to make decisions about the use of antidepressants in pregnancy. This 
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conclusion was underpinned by a robust literature review. Four studies identified that 
information provision and a collaborative decision-making process emerged as the two 
most important factors for women. Women requested clarity of information, which was 
undermined by complexity when interpreting current research about risks and benefits 
of taking antidepressants during pregnancy. It was apparent that contradictory 
information confuses women and health professionals. Midwives should consider that 
when women feel informed there is a clear association with feeling satisfied with the 
decision made (Stepanuk et al, 2013). Therefore, the impact of unclear information 
given to women about using antidepressant medication needs more in depth 
qualitative research not only in the UK but also globally. Further research would help 
to identify accessible information that women will find useful. There is a need to 
understand more about how women problem solve around the uptake of 
antidepressants, as the topic is crucial to the health and wellbeing of women and their 
families when depression in pregnancy is experienced.  
In addition, it was found that women wanted to actively participate in their 
treatment decisions (Patel and Wisner, 2011). Midwives need to have clear instruction 
about how to achieve collaborative discussions with women in a sensitive and caring 
way, which could be facilitated in undergraduate and postgraduate health education. 
In addition, to improve standards of care, provision needs to address service gaps in 
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